stoxline Quote Chart Rank Option Currency Glossary
  
Amyris, Inc. (AMRS)
0.05  0 (0%)    05-09 16:00
Open: 0.064
High: 0.0643
Volume: 46,746,028
  
Pre. Close: 0.05
Low: 0.05
Market Cap: 18(M)
Technical analysis
2023-11-10 4:18:11 PM
Short term     
Mid term     
Targets 6-month :  0.06 1-year :  0.07
Resists First :  0.05 Second :  0.06
Pivot price 0
Supports First :  0.05 Second :  0.04
MAs MA(5) :  0 MA(20) :  0
MA(100) :  0 MA(250) :  0
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  0 D(3) :  0
RSI RSI(14): 0
52-week High :  0.06 Low :  0.05
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ AMRS ] has closed Bollinger Bands are 0% narrower than normal.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: - -
Low: - -
Close: - -
Company Description

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.

Headline News

Wed, 22 May 2024
Amyris, Inc. (AMRS) Gains But Lags Market: What You Should Know - Yahoo Movies Canada

Sun, 12 May 2024
Amyris (AMRS) Surges: Stock Moves 7.1% Higher - Yahoo News UK

Sun, 12 May 2024
Shareholders in Amyris (NASDAQ:AMRS) have lost 68%, as stock drops 12% this past week - Yahoo Canada Shine On

Thu, 21 Sep 2023
E'ville Biz: Upside Foods Scrutinized, JDE Peet's Criticized For Russia Business; Amyris Files for Bankruptcy; Eko ... - evilleeye.com

Thu, 10 Aug 2023
Amyris (NASDAQ:AMRS) Nosedives on Chapter 11 Bankruptcy Filing - TipRanks.com - TipRanks

Thu, 10 Aug 2023
Amyris: Shareholders Likely To Be Wiped Out In Chapter 11 - Sell (NASDAQ:AMRS) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Basic Materials
Industry:
Chemicals - Specialty
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android